Skip to main content
SpringerLink
Log in
Book cover

Hemocoagulative Problems in the Critically Ill Patient pp 73–84Cite as

Inborn Defects of the Coagulative System

  • Chapter
  • First Online:

  • 1305 Accesses

Abstract

Over the course of time, blood coagulation has become a highly sophisticated defense mechanism to detect injury to the body and prevent exsanguinations to enhance survival. Surveillance and rapid, localized hemostatic actions of the coagulation system are necessary given the multiple number of breaches to vascular integrity that occur over a lifetime. The coagulation process was understood until a few years ago as a simple “enzyme cascade mechanism.” It involves an orderly and sequential activation of various coagulation factors from an inactive form to an enzymatically active form (theory of enzymatic “cascade” from the mid-1960s). According to this theory, there are two pathways (intrinsic and extrinsic) that converge in a common pathway when factor X is activated. Currently, it is considered that the two pathways of coagulation activation are not separate, but are interconnected. In fact, factors generated in the extrinsic pathway will activate factors and complexes of the intrinsic pathway. The distinction between the two pathways of coagulation activation is still in use but it is important to underline that there are mechanisms of cross-over among the two. There are many diseases that can result from abnormalities of one or more of the three compartments. Among these we consider the inherited deficiencies of coagulation factors. Congenital coagulation defects are hemophilia A, hemophilia B, von Willebrand disease, inherited thrombophilias, and rare coagulation factor deficiencies (deficiencies of fibrinogen, the plasma protease zymogens prothrombin, factors VII, X, XI, and XII, and prekallikrein, the cofactors factor V and high molecular weight kininogen, and the transaminase factor XIII).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Davie EW (2003) A brief historical review of the waterfall/cascade of blood coagulation. J Biol Chem 278(51):50819–50832

    Article  PubMed  CAS  Google Scholar 

  2. Hoffman M, Monroe DM 3rd (2001) A cell-based model of hemostasis. Thromb Haemost 85(6):958–965

    PubMed  CAS  Google Scholar 

  3. Patthy L (1985) Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell 41(3):657–663

    Article  PubMed  CAS  Google Scholar 

  4. Lindqvist PG, Svensson PJ, Dahlback B, Marsal K (1998) Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss–a possible evolutionary selection mechanism. Thromb Haemost 79(1):69–73

    PubMed  CAS  Google Scholar 

  5. Krem MM, Di Cera E (2001) Molecular markers of serine protease evolution. EMBO J 20(12):3036–3045

    Article  PubMed  CAS  Google Scholar 

  6. Davidson CJ, Tuddenham EG, McVey JH (2003) 450 million years of hemostasis. J Thromb Haemost 1(7):1487–1494

    Article  PubMed  CAS  Google Scholar 

  7. Theopold U, Schmidt O, Soderhall K, Dushay MS (2004) Coagulation in arthropods: defence, wound closure and healing. Trends Immunol 25(6):289–294

    Article  PubMed  CAS  Google Scholar 

  8. Kar A, Potnis-Lele M (2001) Descriptive epidemiology of haemophilia in Maharashtra, India. Haemophilia 7(6):561–567

    Article  PubMed  CAS  Google Scholar 

  9. Fukutake K (2000) Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan. Semin Thromb Hemost 26(1):29–32

    Article  PubMed  CAS  Google Scholar 

  10. Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E (1995) The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 73(2):247–251

    PubMed  CAS  Google Scholar 

  11. Kasper CK, Aronson DL, Davignon G, Foster P, Hillman-Wiseman C, Lusher JM et al (1995) Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 74(3):987–989

    PubMed  CAS  Google Scholar 

  12. Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I (1998) A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis. Thromb Haemost 79(4):872–875

    PubMed  CAS  Google Scholar 

  13. Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J et al (1975) Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 34(2):612

    PubMed  CAS  Google Scholar 

  14. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J (2001) Definitions in hemophilia. Recommendation of the Scientific Subcommittee on factor VIII and factor IX of the Scientific and Standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 85(3):560

    PubMed  CAS  Google Scholar 

  15. Verbruggen B, van Heerde WL, Laros-van Gorkom BA (2009) Improvements in factor VIII inhibitor detection: From Bethesda to Nijmegen. Semin Thromb Hemost 35(8):752–759

    Article  PubMed  CAS  Google Scholar 

  16. Biggs R, Douglas AS, Macfarlane RG, Dacie JV, Pitney WR (1952) Merskey. Christmas disease: a condition previously mistaken for haemophilia. Br Med J 2(4799):1378–1382

    Article  PubMed  CAS  Google Scholar 

  17. Aggeler PM, White SG, Glendening MB, Page EW, Leake TB, Bates G (1952) Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia. Proc Soc Exp Biol Med 79(4):692–694

    PubMed  CAS  Google Scholar 

  18. Giannelli F, Green PM, Sommer SS, Poon M, Ludwig M, Schwaab R et al (1998) Haemophilia B: database of point mutations and short additions and deletions–eighth edition. Nucleic Acids Res 26(1):265–268

    Article  PubMed  CAS  Google Scholar 

  19. Hay CR, Baglin TP, Collins PW, Hill FG, Keeling DM (2000) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors’ Organization (UKHCDO). Br J Haematol 111(1):78–90

    Article  PubMed  CAS  Google Scholar 

  20. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L et al (2006) Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 4(10):2103–2114

    Article  PubMed  CAS  Google Scholar 

  21. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D et al (2000) Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 84(2):160–174

    PubMed  CAS  Google Scholar 

  22. Ginsburg D, Handin RI, Bonthron DT, Donlon TA, Bruns GA, Latt SA et al (1985) Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 228(4706):1401–1406

    Article  PubMed  CAS  Google Scholar 

  23. Verweij CL, de Vries CJ, Distel B, van Zonneveld AJ, van Kessel AG, van Mourik JA et al (1985) Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. Nucleic Acids Res 13(13):4699–4717

    Article  PubMed  CAS  Google Scholar 

  24. Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S et al (1985) Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 66(4):796–802

    PubMed  CAS  Google Scholar 

  25. Haemostasis and Thrombosis Task Force BCfSiH (2001) Investigation and management of heritable thrombophilia. Br J Haematol 114(3):512–528

    Article  Google Scholar 

  26. Kutteh WH, Triplett DA (2006) Thrombophilias and recurrent pregnancy loss. Semin Reprod Med 24(1):54–66

    Article  PubMed  CAS  Google Scholar 

  27. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698–3703

    PubMed  CAS  Google Scholar 

  28. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M et al (2000) Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 342(6):374–380

    Article  PubMed  CAS  Google Scholar 

  29. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698–3703

    PubMed  CAS  Google Scholar 

  30. Kierkegaard A (1983) Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand 62(3):239–243

    Article  PubMed  CAS  Google Scholar 

  31. Tait RC, Walker ID, Perry DJ, Islam SI, Daly ME, McCall F et al (1994) Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 87(1):106–112

    Article  PubMed  CAS  Google Scholar 

  32. Adelberg AM, Kuller JA (2002) Thrombophilias and recurrent miscarriage. Obstet Gynecol Surv 57(10):703–709

    Article  PubMed  Google Scholar 

  33. Lockwood CJ (2002) Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 99(2):333–341

    Article  PubMed  Google Scholar 

  34. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113

    Article  PubMed  CAS  Google Scholar 

  35. Morelli VM, Lourenco DM, D’Almeida V, Franco RF, Miranda F, Zago MA et al (2002) Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis 13(3):271–275

    Article  PubMed  CAS  Google Scholar 

  36. Miletich J, Sherman L, Broze G Jr (1987) Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 317(16):991–996

    Article  PubMed  CAS  Google Scholar 

  37. Foster DC, Yoshitake S, Davie EW (1985) The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci U S A 82(14):4673–4677

    Article  PubMed  CAS  Google Scholar 

  38. Plutzky J, Hoskins JA, Long GL, Crabtree GR (1986) Evolution and organization of the human protein C gene. Proc Natl Acad Sci U S A 83(3):546–550

    Article  PubMed  CAS  Google Scholar 

  39. Ploos van Amstel JK, van der Zanden AL, Bakker E, Reitsma PH, Bertina RM (1987) Two genes homologous with human protein S cDNA are located on chromosome 3. Thromb Haemost 58(4):982–987

    PubMed  CAS  Google Scholar 

  40. Schmidel DK, Tatro AV, Phelps LG, Tomczak JA, Long GL (1990) Organization of the human protein S genes. Biochemistry 29(34):7845–7852

    Article  PubMed  CAS  Google Scholar 

  41. Hiippala ST, Myllyla GJ, Vahtera EM (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81(2):360–365

    PubMed  CAS  Google Scholar 

  42. Stainsby D, MacLennan S, Hamilton PJ (2000) Management of massive blood loss: a template guideline. Br J Anaesth 85(3):487–491

    Article  PubMed  CAS  Google Scholar 

  43. Hathcock JJ, Nemerson Y (2004) Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. Blood 104(1):123–127

    Article  PubMed  CAS  Google Scholar 

  44. Mosesson MW (2007) Update on antithrombin I (fibrin). Thromb Haemost 98(1):105–108

    PubMed  CAS  Google Scholar 

  45. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF (2007) Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 245(5):812–818

    Article  PubMed  Google Scholar 

  46. Sniecinski RM, Chen EP, Tanaka KA (2008) Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery. Blood Coagul Fibrinolysis 19(2):178–179

    Article  PubMed  Google Scholar 

  47. Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K et al (2004) Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 99(5):1564–1569

    Article  PubMed  CAS  Google Scholar 

  48. Levy JH, Tanaka KA (2008) Prohemostatic agents to prevent perioperative blood loss. Semin Thromb Hemost 34(5):439–444

    Article  PubMed  Google Scholar 

  49. Heindl B, Delorenzo C, Spannagl M (2005) High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist 54(8):787–790

    Article  PubMed  CAS  Google Scholar 

  50. Godje O, Haushofer M, Lamm P, Reichart B (1998) The effect of factor XIII on bleeding in coronary surgery. Thorac Cardiovasc Surg 46(5):263–267

    Article  PubMed  CAS  Google Scholar 

  51. Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ (2006) Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 46(6):919–933

    Article  PubMed  CAS  Google Scholar 

  52. O’Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM (2006) Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295(3):293–298

    Article  PubMed  Google Scholar 

  53. Sniecinski R, Szlam F, Chen EP, Bader SO, Levy JH, Tanaka KA (2008) Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg 106(3):713–718, table of contents

    Article  PubMed  CAS  Google Scholar 

  54. Lo B, Fijnheer R, Castigliego D, Borst C, Kalkman CJ, Nierich AP (2004) Activation of hemostasis after coronary artery bypass grafting with or without cardiopulmonary bypass. Anesth Analg 99(3):634–640

    Article  PubMed  CAS  Google Scholar 

  55. Parolari A, Mussoni L, Frigerio M, Naliato M, Alamanni F, Polvani GL et al (2005) The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 130(6):1561–1566

    Article  PubMed  CAS  Google Scholar 

  56. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC et al (2008) The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133(Suppl 6):299S–339S

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesia and Intensive Care, Pediatric Anesthesia and Intensive Care Section, “Policlinico” University Hospital, Catania, Italy

    Marinella Astuto

  2. Postgraduate School of Anesthesia and Intensive Care, Catania University Hospital, Catania, Italy

    Nadia Grasso & Alessandro Trainito

Authors
  1. Marinella Astuto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nadia Grasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessandro Trainito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marinella Astuto .

Editor information

Editors and Affiliations

  1. , Department of Anesthesia and Intensive C, University of Trieste, Strada di Fiume 447, Trieste, I-34149, Italy

    Giorgio Berlot

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Astuto, M., Grasso, N., Trainito, A. (2012). Inborn Defects of the Coagulative System. In: Berlot, G. (eds) Hemocoagulative Problems in the Critically Ill Patient. Springer, Milano. https://doi.org/10.1007/978-88-470-2448-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2448-9_5

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2447-2

  • Online ISBN: 978-88-470-2448-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation